UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 4, 2020
Accession Number:
Submission Type:
CIK:
0001498382
Company Name:
Kintara Therapeutics, Inc.
File Number:
333-249675